Omeros Inventory Turnover Ratio 2009-2020 | OMER

Omeros inventory turnover ratio from 2009 to 2020. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
Omeros Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.821B $0.112B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $158.276B 27.45
Medtronic (MDT) Ireland $130.197B 21.17
Stryker (SYK) United States $69.830B 22.66
Boston Scientific (BSX) United States $50.642B 23.81
Baxter (BAX) United States $43.371B 26.47
Lonza Group Ag (LZAGY) Switzerland $37.160B 0.00
Terumo (TRUMY) Japan $28.414B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $26.613B 0.00
Zimmer Biomet Holdings (ZBH) United States $26.160B 16.46
ResMed (RMD) United States $23.216B 36.64
Smith & Nephew SNATS (SNN) United Kingdom $17.819B 0.00
Sunny Optical Technology (SNPTF) China $15.224B 0.00
Bio-Rad Laboratories (BIO) United States $14.265B 64.93
DiaSorin S.p.A (DSRLF) Italy $12.141B 0.00
Insulet (PODD) United States $11.521B 1141.44
Perrigo (PRGO) Ireland $7.480B 13.38
Shandong Weigao Medical Polymer (SHWGF) China $7.281B 0.00
Canopy Growth (CGC) Canada $7.020B 0.00
Quidel (QDEL) United States $6.753B 53.07
GN STORE NORD (GNNDY) Denmark $6.590B 34.05
Hill-Rom Holdings (HRC) United States $6.583B 18.56
William Demant Holdings (WILYY) Denmark $6.417B 0.00
Haemonetics (HAE) United States $5.433B 32.63
GW Pharmaceuticals (GWPH) United Kingdom $4.055B 0.00
ICU Medical (ICUI) United States $4.006B 29.22
Neogen (NEOG) United States $3.653B 61.88
Agios Pharmaceuticals (AGIO) United States $3.613B 0.00
NuVasive (NUVA) United States $3.327B 26.72
Envista Holdings (NVST) United States $3.169B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.817B 0.00
TG Therapeutics (TGTX) United States $2.249B 0.00
National Vision Holdings (EYE) United States $2.202B 38.10
AtriCure (ATRC) United States $1.972B 0.00
Aurora Cannabis (ACB) Canada $1.583B 0.00
Cardiovascular Systems (CSII) United States $1.346B 0.00
MacroGenics (MGNX) United States $1.162B 0.00
NanoString Technologies (NSTG) United States $1.148B 0.00
Aphria (APHA) Canada $1.128B 0.00
Phibro Animal Health (PAHC) United States $1.013B 20.20
Cerus (CERS) United States $0.977B 0.00
OraSure Technologies (OSUR) United States $0.882B 177.63
InMode (INMD) Israel $0.853B 18.03
PetIQ (PETQ) United States $0.839B 24.25
DFB Healthcare Acquisitions (AHCO) United States $0.750B 126.92
Quanterix (QTRX) United States $0.740B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.734B 52.56
VAREX IMAGING (VREX) United States $0.705B 17.51
Zynex (ZYXI) United States $0.653B 65.53
Meridian Bioscience (VIVO) United States $0.605B 22.79
Vapotherm (VAPO) United States $0.568B 0.00
LeMaitre Vascular (LMAT) United States $0.530B 30.21
Surmodics (SRDX) United States $0.514B 61.90
Lantheus Holdings (LNTH) United States $0.508B 10.22
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.391B 328.67
Cytosorbents (CTSO) United States $0.381B 0.00
Utah Medical Products (UTMD) United States $0.330B 23.98
BioLife Solutions (BLFS) United States $0.329B 146.18
Viemed Healthcare (VMD) United States $0.326B 29.24
Organigram Holdings (OGI) Canada $0.302B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.289B 0.00
HEXO (HEXO) $0.283B 0.00
Female Health (VERU) United States $0.240B 0.00
Chimerix (CMRX) United States $0.225B 0.00
InfuSystems Holdings (INFU) United States $0.215B 119.00
Chembio Diagnostics (CEMI) United States $0.180B 0.00
Exagen (XGN) United States $0.175B 0.00
Bovie Medical (APYX) United States $0.160B 0.00
Evolus (EOLS) United States $0.155B 0.00
Fonar (FONR) United States $0.152B 13.48
Rockwell Medical (RMTI) United States $0.142B 0.00
Liberty Health Sciences (LHSIF) Canada $0.137B 0.00
Surface Oncology (SURF) United States $0.136B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.136B 0.00
MTech Acquisition (KERN) United States $0.133B 0.00
United Health Products (UEEC) United States $0.133B 0.00
Brainsway (BWAY) Israel $0.086B 0.00
Wound Management Technologies (SMTI) United States $0.078B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.076B 0.00
Capricor Therapeutics (CAPR) United States $0.075B 0.00
United-Guardian (UG) United States $0.071B 16.39
Nephros (NEPH) United States $0.067B 0.00
GUARDION HEALTH (GHSI) United States $0.045B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 0.00
ImmuCell (ICCC) United States $0.031B 0.00
NF Energy Saving (BIMI) China $0.026B 0.00
FSD PHARMA INC (HUGE) Canada $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.018B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Myomo (MYO) United States $0.011B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00